Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 130,189 | 13,729 | 0 | N/A |
| Other current assets | 0 | 1,405 | 0 | 0 |
| TOTAL | $131,271 | $15,347 | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2,767 | 1,444 | 0 | N/A |
| Other Non-Current Assets | 55 | 55 | 0 | 0 |
| TOTAL | $2,822 | $1,499 | $N/A | $N/A |
| Total Assets | $134,093 | $16,847 | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 2,271 | 265 | 0 | N/A |
| Accounts payable and accrued liabilities | 2,584 | 2,046 | 0 | 0 |
| Accrued Expenses | 3,734 | 1,582 | 0 | N/A |
| TOTAL | $8,590 | $3,893 | $0 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 3,025 | 2,328 | 0 | N/A |
| Other Non-Current Liabilities | 0 | 1,671 | 0 | 0 |
| TOTAL | $3,025 | $3,999 | $N/A | $N/A |
| Total Liabilities | $11,615 | $7,892 | $0 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 1,441 | N/A | N/A | N/A |
| Common Shares | 10 | 1 | 0 | N/A |
| Retained earnings | -62,254 | -29,819 | 0 | N/A |
| Other shareholders' equity | 0 | 36,788 | 0 | 0 |
| TOTAL | $122,478 | $8,955 | $0 | $N/A |
| Total Liabilities And Equity | $134,093 | $16,847 | $0 | $0 |